Global High-Priority Regulatory Events — June 02, 2026

02-06-2026

02-06-2026

Adani Power Limited released its June 2026 investor presentation, highlighting its position as India's largest private thermal power producer with an operating capacity of 18,330 MW and a locked-in capacity of 23,720 MW. The presentation emphasizes strong growth in Q4 FY26 revenue (+10% YoY to ₹15,989 Cr) and PAT (+64% YoY to ₹4,271 Cr), but also notes a decline in full-year FY26 revenue (-2% YoY to ₹57,865 Cr) and EBITDA (-2% YoY to ₹23,431 Cr). The company has a robust pipeline of 23.7 GW locked-in capacity and expects to benefit from India's growing power demand, though its net debt increased to ₹45,022 Cr from ₹31,023 Cr in FY25.

• · India's electricity consumption per capita is ~1,395 kWh, about 1/3rd of global average.
• · Additional coal-based capacity of 97 GW required by FY35 to meet peak demand.
• · Adani Power has 100% land availability and 100% BTG sets ordered for its 23.7 GW locked-in pipeline.
• · 60% of upcoming capacity is brownfield, enabling faster execution.
• · PPAs awarded to APL under SHAKTI Policy total 13.9 GW.
• · Net debt to continuing EBITDA ratio stood at 2.12x as of FY26.
• · RoCE for FY26 was 17.5%, RoE was 20.9%, and RoA was 18.5%.
• · The presentation notes that India's logistics cost is high, with transportation accounting for ~60% of direct logistics costs.

02-06-2026

An open offer has been announced by five acquirers (Gayathri Boreddy, Jagannath Edla, Radha Krishna Avudari, Mahammad Amaan Shaik, and Ravi Kiran Veeramalla) to acquire up to 97,50,000 equity shares of Midland Polymers Ltd. at ₹10 per share, representing 26.00% of the expanded equity and voting share capital. The offer opens on June 3, 2026 and closes on June 16, 2026, with the Independent Directors Committee opining that the offer price is in accordance with the Takeover Code and prima facie justified. No competitive bid has been received, and all timelines have been revised from the original schedule.

• · The Detailed Public Statement was published on April 7, 2026 in Financial Express (English), Jansatta (Hindi), Pratahkal (Marathi), and Mega Jyothi (Telugu).
• · The Draft Letter of Offer was submitted to SEBI on April 15, 2026, and final observations were received on May 15, 2026.
• · The Letter of Offer dispatch to all public shareholders was completed on May 26, 2026.
• · The Identified Date for determining shareholders eligible to receive the Letter of Offer was revised to May 19, 2026.
• · The offer opening date was revised from May 25 to June 3, 2026, and the closing date from June 8 to June 16, 2026.
• · Payment of consideration for acquired shares is scheduled by July 1, 2026.
• · The Manager to the Offer is Navigant Corporate Advisors Limited (SEBI Registration No: INM000012243).

02-06-2026

Godavari Biorefineries reported a turnaround in FY26 with a profit after tax of INR3.5 crore versus a loss in FY25, driven by a 6% revenue increase to INR2,000 crore and a 15.8% EBITDA rise to INR139 crore. However, EBITDA margin remained flat at 7% for the full year, and the bio-based chemical segment revenue declined to INR578 crore from INR658 crore in the prior year, with specialty chemical contribution shrinking. The company achieved record cane crushing of 2.5 million tons and reduced finance costs by 32% to INR49 crore after repaying INR240 crore in debt.

• · Bio-based chemical segment revenue declined to INR578 crore in FY26 from INR658 crore in FY25, with specialty chemical contribution shrinking from 58% to 61% of segment revenue.
• · Ethanol segment revenue was INR658 crore for FY26, with approximately 98 million liters sold across blending program, ENA, and other grades.
• · Consumer business Jivana revenue stood at INR129 crore for FY26, with expanding retail presence in South India.
• · The company commissioned a 200 KLPD grain-based distillery, expected to add 60 million liters annual ethanol capacity by June 2026.
• · Finance cost reduced 32% YoY to INR49.1 crore after debt repayment of INR240 crore in FY25.
• · Q4 FY26 EBITDA margin improved to 16.2% from 9.8% in Q3 FY26, driven by better absorption of fixed costs and higher sugar operating efficiency.
• · The company is exploring opportunities in bio-butanol, DME, and next-generation renewable technologies.
• · Recognitions include Karnataka State Boiler Safety Award, Sustainability Champion Award at AIDA Annual Distillers Conclave 2026, and recognition at Hannover Messe for digital initiatives.

02-06-2026

On June 02, 2026, Supreme Infrastructure India Limited issued a clarification regarding the open offer managed by Systematix Corporate Services Limited. SEBI's observation letter dated May 25, 2026 requires the acquirers and PACs to proceed with an open offer for 3,09,00,665 equity shares (26% of fully diluted voting capital); however, the acquirers have sought reconsideration of certain observations, including exemption/withdrawal requests, timelines, offer size, escrow, and interest computation. The matter remains under regulatory consideration, and the company itself is not the acquirer.

• · Acquirers/PACs have made a representation to SEBI seeking reconsideration of observations, including exemption/withdrawal request and issues relating to open offer timelines, offer size, escrow requirement and interest computation.
• · The Company is not the acquirer under the open offer; funding of escrow and implementation are obligations of the Acquirers/PACs.
• · The matter is presently under regulatory consideration before SEBI.

02-06-2026

Emirates NBD Bank (P.J.S.C.) launched an open offer to acquire up to 415,586,443 equity shares (26.00% of expanded voting share capital) of RBL Bank Limited from public shareholders under SEBI (SAST) Regulations. As of June 1, 2026, zero equity shares (0.00% of the offer size) had been tendered into the escrow demat account, indicating no public shareholder participation at that point.

• · The open offer is made under SEBI (SAST) Regulations, 2011.
• · The letter of offer was dated May 22, 2026.
• · The escrow demat account is maintained with Ventura Securities Limited (DP ID: IN303116, Client ID: 15744215, PAN: AABCT3335M).
• · Tendered shares are subject to validation and verification of complete documentation before acceptance.
• · The number of shares tendered may differ from the number ultimately accepted by the acquirer.

02-06-2026

PS IT Infrastructure & Services Limited is undergoing Corporate Insolvency Resolution Process (CIRP) with the second meeting of the Committee of Creditors scheduled for June 4, 2026. The meeting will discuss actions taken by the Resolution Professional, ratification of CIRP costs, approval of interim finance for 180 days, and amendments to EOI and Form-G. The CFO has resigned, and the resolution professional seeks guidance from the CoC.

• · Insolvency commencement date: 29/04/2026
• · First CoC meeting held on 25th May 2026
• · CFO Rajesh Baliram Patole resigned on 23 May 2026, resignation forwarded to RP on 01 June 2026
• · Proposed interim finance amount not specified in the filing
• · Voting rights of financial creditors range from 2.44% to 26.57%

02-06-2026

Bombay Burmah Trading Corporation Limited has issued a newspaper notice regarding the upcoming transfer of unpaid dividends for FY 2018-19 and corresponding equity shares to the Investor Education and Protection Fund (IEPF) on September 18, 2026. The company has also launched the second 'Saksham Niveshak' 100-day campaign (April 1 to July 9, 2026) to help shareholders update KYC, bank mandates, and claim unclaimed dividends. Shareholders must act by September 4, 2026, to avoid transfer of their shares and dividends to the IEPF.

• · Unpaid dividend for FY 2018-19 and corresponding shares will be transferred to IEPF on September 18, 2026.
• · Shareholders must submit claims to KFin Technologies by September 4, 2026, to prevent transfer.
• · The 'Saksham Niveshak' campaign runs from April 1, 2026, to July 9, 2026.
• · Shareholders can claim transferred shares/dividends from IEPF using Form IEPF-5 after obtaining an entitlement letter from the company.
• · Contact details provided: KFin Technologies (Hyderabad, +91 40 7961 5565, einward.ris@kfintech.com) and company email investorservices@bbtcl.com.

02-06-2026

Plains GP Holdings, L.P. announced the promotion of Russ Montgomery to Vice President, Accounting and Chief Accounting Officer effective September 1, 2026, and the retirement of Chris Herbold as Senior Vice President, Finance and Chief Accounting Officer effective August 31, 2026.

• · Russ Montgomery, 50, previously served as Vice President, Controller of PAA since 2019.
• · Montgomery joined PAA in September 2002 and spent four years at Arthur Andersen LLP prior.
• · Chris Herbold's retirement is effective August 31, 2026, and Montgomery's promotion is effective September 1, 2026.

02-06-2026

Plains All American Pipeline, L.P. (PAA) announced on June 1, 2026, that Russ Montgomery will be promoted to Vice President, Accounting and Chief Accounting Officer effective September 1, 2026, succeeding Chris Herbold, who is retiring on August 31, 2026. Montgomery has served as Vice President, Controller since 2019 and has been with the company since 2002.

• · Russ Montgomery, age 50, has been with PAA since September 2002, previously serving as Vice President, Controller (2019–present), Controller (2010–2019), Director of Operational Accounting (2008–2010), Manager of Crude Oil Accounting (2005–2008), and SEC and Financial Reporting Senior Analyst (2002–2005).
• · Prior to joining PAA, Montgomery spent four years at Arthur Andersen LLP.
• · Chris Herbold is retiring effective August 31, 2026.

02-06-2026

Hims & Hers Health, Inc. completed its acquisition of Eucalyptus, advancing its position as the world's largest consumer health platform. The acquisition extends the company's leadership across Australia, Canada, Germany, Japan, and the United Kingdom, building on prior acquisitions of ZAVA and Livewell. The company reaffirmed its long-term targets of $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA by 2030, but faces integration risks and uncertainties related to international expansion and achieving these financial goals.

• · The acquisition closed pursuant to the terms of the definitive agreement.
• · Eucalyptus has served more than 850,000 customers to date (as of May 2026).
• · Hims & Hers now has a leading presence across the US, UK, Australian, and Canadian markets, with a growing presence in France, Germany, Ireland, Spain, and Japan.
• · The company can now reach hundreds of millions of people across four continents.
• · The press release includes cautionary language about forward-looking statements, highlighting risks related to integration, international expansion, regulatory compliance, customer adoption, and achieving long-term financial targets.

02-06-2026

On June 2, 2026, Genco Shipping & Trading Limited entered into the Third Amendment to its Shareholder Rights Agreement, eliminating the defined term 'Acting in Concert' based on shareholder feedback and board assessment. The amendment does not alter other provisions regarding concerted activity, including group formation under Rule 13d-5(b)(1), and the Rights Agreement remains substantially similar to those of other public companies, intended to protect shareholder long-term value and prevent coercive control without a premium.

• · The Third Amendment was entered into on June 2, 2026.
• · The amendment eliminates the defined term 'Acting in Concert' from the Rights Agreement.
• · Other provisions regarding concerted activity, including group formation under Rule 13d-5(b)(1), remain unchanged.
• · The Rights Agreement was originally dated October 1, 2025.
• · The amendment is intended to enable all shareholders to realize long-term value and provide the Board sufficient time to fulfill fiduciary duties.

02-06-2026

Hallador Energy acquired approximately 460 MW of Siemens gas turbines and related equipment for $350 million ($760/kW), with an additional $100 million in transportation/refurbishment/logistics costs, to accelerate its Merom natural gas project in MISO Zone 6. The acquisition secures long-lead-time equipment at an attractive valuation, and the project is targeted to begin generating revenue between late 2028 and mid-2029. The company had no outstanding bank debt as of March 31, 2026, maintains a $120 million credit facility, and has a contracted sales book of over $2.1 billion, including a previously announced 12-year capacity agreement valued at over $1 billion. However, the project remains subject to multiple milestones (MISO ERAS study completion by September 2026, GIA receipt, financing, offtake agreements, permits) and Hallador retains the option to sell the equipment or project rather than develop it.

• · The turbines have never been previously fired and are being acquired at what the company believes to be an attractive valuation compared to new equipment alternatives given current delivery windows.
• · The $450 million delivered price represents more than half the estimated total project cost for the Merom simple cycle project.
• · Hallador had no outstanding bank debt as of March 31, 2026.
• · The MISO ERAS study is anticipated to be completed in September 2026, after which Hallador will make a final investment decision.
• · Hallador retains optionality to: advance the full project, sell the project with equipment, or sell the equipment on a standalone basis.
• · The acquisition secures critical long-lead-time equipment in a market with significant supply constraints and extended lead times for new turbine deployment.

02-06-2026

BlockchAIn Digital Infrastructure, Inc. filed an S-1 registration statement with the SEC on June 2, 2026, for its initial public offering. The company, which focuses on digital infrastructure and AI data centers, reported a net loss of $41.9 million for the year ended December 31, 2025, compared to a net loss of $8.5 million for the successor period from February 8 to December 31, 2024, reflecting a significant increase in losses. Revenue grew to $5.0 million in 2025 from $0.9 million in the prior successor period, but the company remains unprofitable with an accumulated deficit of $53.5 million as of March 31, 2026.

• · The company's accumulated deficit was $53.5 million as of March 31, 2026.
• · Revenue for the three months ended March 31, 2026, was not separately disclosed in the provided excerpt.
• · The company has a history of losses and expects to continue incurring losses.
• · Jerry Tang has served as CEO since April 11, 2025, and also leads One BlockchAIn and TigerDC.
• · Jolienne Halisky was appointed CFO on March 16, 2026.
• · The filing includes financial data for both the predecessor (pre-February 8, 2024) and successor (post-February 8, 2024) periods due to a corporate reorganization.

02-06-2026

US Elemental Inc. filed an S-4 registration statement on June 2, 2026, in connection with a proposed business combination with Constellation Acquisition Corp. I (CSTA), a SPAC, and HiTech Minerals Inc., a wholly-owned subsidiary of Jindalee Lithium Limited. The transaction, valued at an equity value of $500 million, will result in HiTech (owner of the McDermitt Lithium Project) becoming a wholly-owned subsidiary of US Elemental, with US Elemental becoming a public company listed on Nasdaq under the symbol 'ULIT'. The filing includes three shareholder proposals: approval of the business combination, approval of the merger plan, and an adjournment proposal, with a minimum cash condition of $14 million required for closing.

• · The business combination agreement was entered into on April 9, 2026.
• · CSTA units will be detached into one Class A ordinary share and one-third of a CSTA warrant upon closing.
• · CSTA Class B ordinary shares will automatically convert into Class A ordinary shares before the exchange.
• · US Elemental intends to list on Nasdaq under symbols 'ULIT' (common stock) and 'ULITW' (warrants).
• · CSTA ordinary shares and warrants currently trade on OTCQB Basic Market under symbols 'CSTAF' and 'CSTWF'.
• · The minimum cash condition includes cash from PIPE Financing, trust account amounts (minus redemptions and taxes), minus CSTA transaction expenses.
• · The filing is preliminary and subject to completion, dated June 1, 2026.

02-06-2026

NCS Multistage Holdings, Inc. has entered into a definitive merger agreement with Weatherford International plc, under which Weatherford will acquire NCS in an all-stock and mixed consideration transaction expected to close in the second half of 2026. Holders of more than 50% of NCS common stock have already consented to the merger, eliminating the need for further stockholder approval.

• · The Merger Agreement includes a no-shop clause and provisions for superior proposals.
• · NCS restricted stock units (RSUs) and equivalent stock units (ESUs) will be assumed by Weatherford, with terms continuing including vesting, but the Max Value Cap on ESUs will cease.
• · NCS performance stock units (PSUs) will be assumed with performance goals deemed satisfied at the greater of target and actual level as of the Merger Agreement date.
• · NCS options with an exercise price less than the value of the Share Consideration will be assumed and converted; those with an exercise price equal to or greater will be cancelled without consideration.
• · Non-employee director NCS DSUs will automatically vest and settle in NCS common stock immediately prior to the Effective Time.
• · The Outside Date for closing is May 31, 2027, after which either party may terminate if the merger has not been completed.
• · The Merger is subject to customary closing conditions including regulatory approvals, effectiveness of an S-4 registration statement, and no Material Adverse Effect.

02-06-2026

Honeywell appointed Jillian Evanko, CEO of Duravant, to its Board as an Independent Director and Audit Committee member, effective immediately. The appointment comes ahead of the planned spin-off of Honeywell's Aerospace business on June 29, 2026, after which several directors will move to the Aerospace board. Evanko brings over 25 years of industrial and manufacturing experience, including as former CEO of Chart Industries.

• · Evanko, 48, has more than 25 years of experience across industrial and manufacturing sectors.
• · She spent nearly a decade at Chart Industries, most recently as President and CEO and prior as CFO.
• · She holds an MBA from The University of Notre Dame and a BS in Business Administration from La Salle University.
• · Following the Aerospace spin-off on June 29, 2026, Craig Arnold, Bill Ayer, Scott Davis, and Deborah Flint will join the Honeywell Aerospace board.
• · Evanko currently serves as an independent director of Greif, Inc. and previously served on boards of Chart Industries, Parker Hannifin, and Alliant Energy.

02-06-2026

Tempest Therapeutics entered into a warrant exercise and inducement agreement on May 28, 2026, resulting in approximately $2.0 million in gross proceeds from the cash exercise of existing warrants at a reduced price of $1.73 per share. The company issued new warrants to purchase up to 2,344,828 shares at the same reduced price, along with placement agent warrants. The transaction provides immediate cash but significantly dilutes existing shareholders, and the new warrants are subject to stockholder approval before becoming exercisable.

• · Existing warrants were originally issued in November 2025 at an exercise price of $3.50 per share; reduced to $1.73 per share.
• · New warrant exercise price is $1.73 per share, expires May 29, 2028.
• · New warrant exercisable only after stockholder approval under Nasdaq rules.
• · Placement agent warrants have an exercise price of $2.1625 per share.
• · Company must file a resale registration statement within 30 days and use best efforts to have it effective within 45 days (75 days if SEC review).
• · Placement agent receives 7% cash fee and 7% warrant coverage on any future cash exercise of new warrants within 24 months of issuance.
• · Shares from existing warrants were registered under Form S-1 (File No. 333-292026); new warrants and placement agent warrants are unregistered.

02-06-2026

General Fusion Inc., a fusion energy company, announced its leadership team will participate in three investor and industry conferences in June 2026 as it prepares to go public via a business combination with Spring Valley Acquisition Corp. III (SVAC). The company highlighted its LM26 fusion demonstration machine, which began operating in early 2025 and aims to achieve key fusion milestones. However, the filing contains extensive forward-looking statements cautioning about risks including potential failure to complete the business combination, inability to commercialize MTF technology, and capital raising uncertainties.

• · General Fusion was established in 2002 and is headquartered in Vancouver, Canada.
• · LM26 is the first MTF demonstration machine built at commercially relevant scale, mechanically compressing plasma with a lithium liner.
• · LM26 aims to achieve plasma heating to 1 keV (10 million degrees Celsius), then 10 keV (100 million degrees Celsius), and ultimately the Lawson criterion.
• · Spring Valley I completed a business combination with NuScale Power; Spring Valley II with Eagle Nuclear Energy Corp.
• · The business combination agreement was dated January 21, 2026, and involves SVAC continuing from Cayman Islands to British Columbia, amalgamation with NewCo, and name change to General Fusion Group Ltd.
• · The filing includes a PIPE Financing risk regarding convertible preferred shares and warrants.

02-06-2026

American Rebel Holdings Inc. filed a DEF 14A proxy statement detailing executive compensation, related-party transactions, and a proposal to ratify GBQ Partners LLC as independent auditor for FY2026. Key executive changes include Doug Grau stepping down as President and Interim Principal Accounting Officer on July 1, 2025, to lead a new subsidiary, American Rebel Productions, LLC. The filing also reveals significant related-party transactions, including an outstanding $400,000 director loan from Larry Sinks that remains unpaid as of December 31, 2025, and the issuance of Series D Convertible Preferred Stock to executives and directors to settle accrued bonuses and fees totaling over $2.0 million.

• · No named executive officers exercised stock options or had restricted stock units vest in FY2025 or FY2024.
• · No outstanding equity awards (unexercised options or unvested stock) were held by named executive officers as of December 31, 2025.
• · The company does not offer any annuity, pension, or retirement benefits to officers, directors, or employees.
• · Director Larry Sinks received $36,000 in consulting fees in addition to his director compensation.
• · The company leases facilities from entities owned by former Champion founder Mr. Crosby, believed to be at or below market rate.
• · As of January 1, 2025, Messrs. Ross, Lambrecht, and Grau each vested conversion rights in 10,000 additional shares of Series A Preferred Stock, convertible into 5,000,000 shares of common stock each.
• · Ross and Lambrecht each hold additional 26,250 and 6,250 shares of Series A Preferred respectively, convertible annually starting January 1, 2026 at a rate of 500 to 1.

02-06-2026

Breeze Acquisition Corp. II completed its initial public offering (IPO) of 14,000,000 units (including partial exercise of the over-allotment option) at $10.00 per unit, generating gross proceeds of $140,000,000, and simultaneously sold 470,000 private placement units to Breeze Sponsor II, LLC for $4,700,000. A total of $144,700,000 was placed in a trust account. However, the auditor's report includes a going concern explanatory paragraph noting substantial doubt about the Company's ability to continue as a going concern, as it has no approved plan to extend the business combination deadline beyond May 14, 2027 and lacks capital resources to fund operations and complete a business combination.

• · The Company was incorporated in the Cayman Islands on August 20, 2025 and had not commenced any operations as of May 14, 2026.
• · Transaction costs totaled $5,710,654, including $1,562,500 in cash underwriting fees and $3,729,654 in other offering costs.
• · The Company has until May 14, 2027 to complete a business combination, with no approved plan to extend the deadline.
• · The auditor, CBIZ CPAs P.C., has served as the Company's auditor since 2025.
• · The balance sheet shows total assets of $126,393,403, total liabilities of $2,581,609, and shareholders' deficit of $1,500,706.

02-06-2026

BurTech Acquisition Corp II completed its initial public offering (IPO) of 8,000,000 units at $10.00 per unit, generating gross proceeds of $80,000,000, and a simultaneous private placement of 252,000 units at $10.00 per unit for $2,520,000. A total of $80,400,000 was deposited into a trust account for public shareholders. However, the company's auditor has raised substantial doubt about its ability to continue as a going concern due to insufficient cash and working capital to sustain operations for one year.

• · The company has not yet commenced operations and will not generate operating revenues prior to a business combination.
• · Transaction costs totaled $1,386,506, including an $800,000 underwriting fee.
• · The trust account holds $80,400,000 ($10.05 per unit) invested in U.S. government securities or money market funds.
• · The company must complete a business combination with a target having a fair market value of at least 80% of trust assets.
• · The company's auditor, WithumSmith+Brown, PC, has been the auditor since 2025.
• · The company is an emerging growth company and has elected not to use the extended transition period for new accounting standards.

02-06-2026

This 8-K filing reports a Seventh Addendum to the Sixth Amended and Restated Service Agreement between Comenity Bank and Comenity Servicing LLC, effective June 1, 2026. The addendum modifies certain services and performance standards related to issues management, including amended service descriptions and new performance metrics (e.g., closing 90% of issues within 250 days, completing 90% of Level 3 consumer containment/remediation within 210 days), while deleting previous containment standards. No financial amounts or quantitative financial data are disclosed in the filing.

• · The addendum amends Appendix A (Services) and Appendix B (Performance Standards) of the existing Sixth Amended and Restated Service Agreement dated January 1, 2025.
• · Previous performance standards for containing non-technical and technology/system-dependent issues impacting customers were deleted.
• · The agreement continues in full force and effect except as amended by this addendum.

02-06-2026

Arshiya Limited, under Corporate Insolvency Resolution Process (CIRP), has given prior intimation of the 16th Committee of Creditors (CoC) meeting scheduled for June 3, 2026. The filing does not contain any financial results or period-over-period comparisons, only a procedural update regarding the insolvency process.

• · The company is under Corporate Insolvency Resolution Process (CIRP).
• · The 16th CoC meeting is scheduled for June 3, 2026.
• · Resolution Professional Pankaj Mahajan holds IBBI Registration No: IBBI/IPA-001/IP-P00836/2017-2018/11420.
• · The company's registered office is at Arshiya FTWZ, CO-1, Survey Nos. 178/3 & 178/4, At Post - Sai Village, Taluka - Panvel, District - Raigad, Pin code - 410 221.

02-06-2026

Jagsonpal Pharmaceuticals Limited has completed the extinguishment of 16,00,000 equity shares (face value ₹2 each) bought back through a tender offer, reducing its total issued, subscribed, and paid-up share capital from 6,71,39,150 shares (₹13,42,78,300) to 6,55,39,150 shares (₹13,10,78,300). The buyback was conducted in compliance with SEBI (Buy-Back of Securities) Regulations, 2018, with the tendering period from May 8 to May 14, 2026, and extinguishment confirmed by NSDL and CDSL. Post-buyback, the promoter/promoter group shareholding increased from 67.71% to 69.36%, while foreign investors' shareholding decreased from 3.33% to 30.64% (likely a typo in the filing; the pre-buyback foreign investor count appears inconsistent with the post-buyback figure).

• · The buyback tendering period was May 8, 2026 to May 14, 2026.
• · All 16,00,000 equity shares extinguished were in dematerialized form; no physical shares were tendered.
• · Post-buyback, the 'Others (Public, Public Bodies Corporate etc.)' category shareholding decreased from 28.32% to 0% (implied by the post-buyback table showing only Promoter and Foreign Investors categories).
• · The pre-buyback foreign investors' shareholding was 22,37,115 shares (3.33%), but the post-buyback figure shows 2,00,80,940 shares (30.64%), which appears inconsistent with a reduction of only 16,00,000 shares—likely a data error in the filing.
• · The extinguishment was confirmed by NSDL on May 27, 2026 and by CDSL on June 1, 2026.

02-06-2026

Firefly Aerospace Inc. priced a follow-on public offering of 12,000,000 shares of common stock at $48.00 per share, with an additional 1,800,000 shares available to underwriters. The offering closed on June 1, 2026, and includes both primary shares from the company and secondary shares from selling stockholders.

• · The offering was priced on May 28, 2026 and closed on June 1, 2026.
• · Underwriters have a 30-day option to purchase up to an additional 1,800,000 shares.
• · The Underwriting Agreement includes customary representations, warranties, and indemnification provisions.

02-06-2026

SKIL Infrastructure Ltd, currently under Corporate Insolvency Resolution Process (CIRP), has informed stock exchanges that the Sixth Committee of Creditors (CoC) meeting will be held on June 2, 2026, via virtual mode. The company has been under CIRP since an NCLT Mumbai order dated February 1, 2024, with Purusottam Behera serving as the Resolution Professional.

• · Company is under CIRP as per NCLT Mumbai order dated February 1, 2024.
• · Resolution Professional Purusottam Behera holds IBBI Registration No. IBBI/IPA-002/IP-N00940/2019-20/12993 (AFA valid till December 31, 2026).
• · Meeting will be conducted through audio-visual means in virtual mode at 4:00 PM on June 2, 2026.

02-06-2026

Oscar Health, Inc. announced the transition of Mario Schlosser from President of Technology and Chief Technology Officer to Co-Founder & Advisor to the CEO, effective June 1, 2026, under an amended employment agreement. His new role focuses on accelerating the company's AI and digital health initiatives, and he will continue serving on the Board of Directors. The agreement reduces his compensation: base salary is set at $370,000 with no future annual bonuses, no long-term incentive or equity awards, and no severance or healthcare subsidies upon termination.

• · The amended agreement is effective June 1, 2026, and continues until terminated per its terms.
• · Mr. Schlosser will no longer be eligible for annual bonuses starting calendar year 2026.
• · He will not receive any long-term incentive or equity awards during the term, but will continue vesting in previously granted equity awards.
• · No cash severance or company-subsidized healthcare coverage upon termination.

02-06-2026

Bluejay Diagnostics (NASDAQ: BJDX) announced a strategic partnership with Argonaut Manufacturing Services to establish scalable U.S.-based manufacturing capabilities for its Symphony™ platform, aiming to reduce reliance on overseas manufacturing and mitigate risks from international sourcing and tariffs. The collaboration supports Bluejay's clinical development programs and future commercialization, but the Symphony System remains an investigational device without FDA clearance, and the company has no current revenue from the platform.

• · The partnership is intended to enhance supply chain resilience and reduce risks from international sourcing and import tariffs.
• · Bluejay's Symphony System is an investigational device limited by U.S. law to investigational use only.
• · The SYMON Clinical Study Program includes three studies: SYMON-I (NCT06181604), SYMON-II (NCT06654895), and SYMON-III (NCT07425587).
• · SYMON-II is the pivotal study to validate SYMON-I outcomes and support a 510(k) application to the FDA.
• · The IL-6 Test is designed to provide results in approximately 20 minutes from sample-to-result.
• · Argonaut was founded by former executives from Thermo Fisher Scientific, Affymetrix, and Allergan.

02-06-2026

Picard Medical, Inc. terminated Bernard Skaggs as CFO effective June 1, 2026, and appointed Georgina Smith, 54, as Chief Accounting Officer on the same date. Smith previously served as Controller of SynCardia Systems, LLC from January 2026 to May 2026 and held accounting leadership roles at Rain Bird Corporation and Tucson Electric Power. No related party transactions or compensatory arrangements were disclosed.

• · Georgina Smith is a Certified Public Accountant in Arizona and holds an MBA and BS in Accounting from the University of Arizona.
• · Smith served as Controller of SynCardia Systems, LLC (a subsidiary) from January 2026 to May 2026 before her appointment.
• · No arrangements or understandings exist between Smith and any other person regarding her selection as CAO.
• · No related party transactions requiring disclosure under Item 404(a) of Regulation S-K were reported.

02-06-2026

Borealis Foods Inc. reported a net loss of $18.977M for FY2025, a 25.1% improvement from a $25.327M loss in FY2024, driven by revenue growth of 8.7% to $30.080M and a 4-percentage-point gross margin expansion to 12%. However, the company remains unprofitable with a loss from operations of $11.035M, and interest expense increased 18.3% to $5.986M. The company is pursuing additional financing to scale production and normalize vendor payment terms.

• · Sales discounts & allowances decreased slightly from $1.431M to $1.396M, remaining at 5% of gross sales.
• · Cost of goods sold as a percentage of net revenue improved from 84% to 82%.
• · Total SG&A expenses dropped significantly from $22.594M (82% of revenue) to $14.547M (48% of revenue), a 35.6% reduction.
• · Advertising expense was cut by 58.9% from $5.733M to $2.354M.
• · General & administrative expenses fell 29.2% from $12.751M to $9.034M.
• · The company recorded a $2.007M impairment loss in FY2025 vs. none in FY2024.
• · Net cash used in investing activities was minimal at $0.066M in FY2025 vs. $1.907M in FY2024.
• · The company has not generated a negative gross margin quarter since Q2 2025.
• · Borealis is pursuing equity offerings, convertible debt, and strategic partnerships for additional working capital.

02-06-2026

ESAB Corporation completed its acquisition of Eddyfi Technologies, a global leader in advanced inspection and monitoring technologies, on June 2, 2026. The acquisition aims to extend ESAB's workflow solutions into inspection and monitoring, accelerate growth, and improve margins. ESAB will provide updated FY2026 guidance including one month of Eddyfi's results on its Q2 earnings call.

• · ESAB's Q2 2026 results will include only one month of Eddyfi's financial performance (June).
• · Eddyfi serves customers in more than 110 countries.
• · Eddyfi is headquartered in Québec, Canada.
• · ESAB serves customers in approximately 150 countries.

02-06-2026

Greenpro Capital Corp. (GRNQ) entered into a subscription agreement on May 29, 2026, for a private placement of 28,949 shares of common stock at $1.7272 per share, raising aggregate gross proceeds of $50,000. The shares were issued to the company's CEO, President and Director, Mr. Lee Chong Kuang, in a non-brokered, exempt transaction. While the immediate capital raised is modest ($50K), the filing reveals significant insider ownership: following the offering, Mr. Lee directly holds 10.38% of the outstanding common stock, and together with his spouse holds approximately 11.3%.

• · The offering was exempt from registration under Section 4(a)(2) of the Securities Act and Regulation D/Regulation S; the purchaser represented accredited investor status.
• · No underwriters were involved in the offering; proceeds will be used for operating capital.
• · The company's total outstanding shares after the offering is 18,062,072.
• · The filing date of the 8-K is June 2, 2026.

02-06-2026

Dhanuka Agritech Limited announced a buyback of up to 500,000 equity shares (face value ₹2 each) at ₹1,400 per share, for an aggregate consideration of ₹70 Crore, representing 4.20% of the company's paid-up equity capital and free reserves as of March 31, 2026. The buyback will be conducted via a tender offer on a proportionate basis, with the offer opening on June 4, 2026, and closing on June 10, 2026. The buyback is within the statutory limit of 10% of paid-up capital and free reserves, and the company has reserved a category for small shareholders with a higher entitlement ratio.

• · Record date for determining eligible shareholders: May 29, 2026
• · Buyback offer opens: June 4, 2026; closes: June 10, 2026
• · Last date for receipt of completed tender forms: June 10, 2026 (by 5:00 PM IST)
• · Last date for dispatch of share certificates/payment: June 17, 2026
• · Last date for extinguishment of equity shares: June 29, 2026
• · Small shareholders (reserved category) entitlement ratio: 1 equity share for every 15 held
• · General category shareholders entitlement ratio: 5 equity shares for every 518 held
• · Buyback is within the statutory limit of 10% of paid-up equity capital and free reserves
• · Manager to the buyback: Sundae Capital Advisors Private Limited (SEBI Regn. No. INM000012494)
• · Registrar to the buyback: Bigshare Services Private Limited (SEBI Regn. No. INR000001385)

02-06-2026

Promoter Sunil Purushottanm Agarwal and other promoter group entities created pledges on 9,00,000 shares each with IIFL Capital Services Ltd and Motilal Oswal Financial Services Ltd on June 1, 2026, solely for availing margin trading facility, without any transfer of ownership or control. Post-creation, total promoter encumbered shares stand at 95,81,000 (1.05% of total capital) for Sunil Agarwal and 96,02,000 (1.06%) for Santanu Agarwal, while other promoters like Equilibrated Venture Cflow Pvt. Ltd. already have 7,72,05,002 shares (8.49%) encumbered. The filing also details five existing pledge agreements with security cover ranging from Rs. 1.07 Crore to Rs. 6.80 Crore, all for margin trading purposes.

• · The filing includes details of five existing pledge agreements with dates 18.05.2026, 20.05.2026, 14.05.2026, 15.05.2026, and 01.06.2026, all for margin trading facility.
• · Security cover to amount involved ratio for all pledges is 1.62 or 1.67.
• · No encumbrance is related to any debt instruments (debentures, commercial paper, etc.).
• · Other promoter entities (PRO FITCCH PVT. LTD., PRI CAF PVT. LTD., Equilibrated Venture Cflow Pvt. Ltd., Suneeti Agarwal, Suneeti Dolaa Private Trust) reported no new encumbrance events on this date.

02-06-2026

Concord Biotech Limited has received USFDA approval for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL. The product is an immunosuppressant indicated for prophylaxis of organ rejection in transplant patients. The U.S. market for this product is estimated at approximately US$30 million, and the approval is expected to support Concord Biotech's growth strategy in the U.S. and international markets. No negative or flat metrics are mentioned in the filing.

02-06-2026

Delhivery Limited has incorporated a wholly owned subsidiary named 'Delhivery Fintech Distribution Private Limited' on June 2, 2026, following board approval on May 16, 2026. The subsidiary is expected to support the company's expansion into fintech distribution. No financial figures or performance metrics were disclosed in this filing.

• · The subsidiary was incorporated under the Ministry of Corporate Affairs on June 2, 2026.
• · The subsidiary's name is 'Delhivery Fintech Distribution Private Limited'.
• · The board had approved the incorporation on May 16, 2026.
• · The disclosure is made under Regulation 30 of SEBI Listing Regulations.

02-06-2026

StandardAero, Inc. announced a leadership transition, appointing 35-year industry veteran and current Lead Independent Director Paul McElhinney as CEO, effective October 1, 2026, succeeding retiring CEO Russell Ford. Ford will serve as Executive Chairman through December 31, 2026, and remain a director thereafter. The company also confirmed its full-year 2026 guidance, previously issued on May 7, 2026, indicating no change in financial outlook.

• · CEO transition date is October 1, 2026; Chairman transition date is January 1, 2027.
• · Russell Ford's employment and separation date is December 31, 2026 or earlier.
• · McElhinney's employment agreement includes a 5-year initial term with automatic 1-year renewals.
• · Upon a qualifying termination within 24 months after/6 months before a change in control, McElhinney receives 2.0 times base salary plus target bonus, versus 1.5 times for other qualifying terminations.
• · Ford's transition agreement includes continued vesting of restricted shares post-separation and full vesting of restricted stock units and options upon separation.
• · No financial performance metrics (e.g., revenue, profit) were disclosed in this filing; only guidance confirmation.

02-06-2026

Travere Therapeutics entered into a license and collaboration agreement with Everest Medicines to develop and commercialize civorebrutinib (EVER001), a covalent reversible BTK inhibitor, for all therapeutic uses outside of China and certain East/Southeast Asian countries. Travere will pay an upfront payment of $112.5 million and is eligible for up to approximately $1.03 billion in additional milestone payments, plus tiered royalties on net sales. The agreement expands Travere's pipeline into immune-mediated kidney diseases, but carries significant financial obligations and development risks.

• · The license is exclusive for the Territory (outside China and certain East/Southeast Asian countries) and includes a sublicense to third-party patents.
• · Travere cannot exercise rights outside renal disease until Everest pays a fee to third-party licensors.
• · Travere grants Everest a non-exclusive, royalty-free license to intellectual property generated under the agreement for use outside the Territory.
• · Development costs for global clinical trials will be shared between Travere and Everest.
• · Travere must use commercially reasonable efforts to develop, obtain regulatory approval for, and commercialize at least one product in the U.S. and additional major markets.
• · Royalties range from high single-digit to double-digit percentages based on annual net sales thresholds, subject to customary reductions.
• · The agreement is subject to HSR antitrust waiting period and other customary conditions.
• · Travere can terminate the agreement in its entirety or on a region-by-region basis, and can be reimbursed for the upfront payment if Everest fails to complete initial technology transfer.
• · Everest can terminate if Travere challenges licensed patents or ceases all material development for 12 consecutive months.
• · Upon early termination, Travere must grant Everest a worldwide exclusive license to its generated IP and transfer regulatory filings.

02-06-2026

Dollar General Corp reported total revenues of $10.8 billion for the 13 weeks ended May 1, 2026, up from $10.4 billion in the same period last year, with net income rising to $444.1 million from $391.9 million. While revenues and gross profit increased, selling, general and administrative expenses also grew, and dividends per share remained flat at $0.59. The filing includes detailed financial statements and forward-looking statements highlighting risks such as tariff uncertainty, government assistance reductions, and ongoing strategic initiatives.

• · Interest expense, net decreased significantly from $64.6M to $47.2M, a 26.9% decline.
• · Income tax expense increased from $119.6M to $147.2M, a 23.1% rise.
• · Current portion of long-term obligations decreased slightly from $14.4M to $13.3M.
• · Deferred income taxes increased from $1.04B to $1.09B.
• · Accrued expenses and other decreased from $1.26B to $1.14B.
• · Income taxes payable more than doubled, from $99.4M to $195.7M.
• · Merchandise inventories increased from $6.33B to $6.64B.
• · Goodwill remained unchanged at $4.34B.

02-06-2026

Phoenix Energy One, LLC entered into Amendment No. 9 to its Senior Secured Credit Agreement on June 1, 2026, which permits the Company to issue certain junior lien notes subject to conditions and limitations. The amendment involves Phoenix Operating LLC as borrower, Fortress Credit Corp. as administrative agent, and the guarantors and lenders party thereto.

• · Amendment No. 9 was entered into on June 1, 2026 (the Amendment No. 9 Effective Date).
• · The amendment permits the Company to issue certain junior lien notes, subject to conditions and limitations described in the Credit Agreement.
• · The original Credit Agreement was entered into on August 12, 2024.
• · The filing was signed by Curtis Allen, Chief Financial Officer, on June 2, 2026.
• · The Company is an emerging growth company (checked 'no') and trades on NYSE American LLC under symbol PHXE.P.

02-06-2026

Arxis, Inc. announced two acquisitions: a definitive agreement to acquire Omnetics Connector Corporation in an all-stock transaction expected to close in Q3 2026, and the completed all-cash acquisition of MagCanica Inc. on June 1, 2026. The combined purchase price is approximately $890 million, representing 12x FY27 estimated adjusted EBITDA. Both acquisitions will operate within Arxis' Electronic Components segment.

• · Omnetics acquisition is an all-stock transaction subject to lockup provisions; MagCanica acquisition was all-cash.
• · Omnetics is headquartered in Minneapolis, Minnesota, and was founded in 1984.
• · MagCanica was founded in 2000 and was previously owned by its founders and employees.
• · The Omnetics transaction is subject to customary regulatory approvals and closing conditions.
• · Arcline Investment Management has over $30 billion in assets under management.

02-06-2026

NorthWestern Corporation (d/b/a NorthWestern Energy) entered into a secured term loan credit agreement dated May 27, 2026, with Bank of America, N.A. as administrative agent and several lenders, including BofA Securities, BMO Bank, KeyBank, and U.S. Bank as joint lead arrangers. The agreement establishes a term loan facility with an applicable margin of 0.85% per annum for Term SOFR loans and 0.0% for Base Rate loans, and includes financial covenants such as a consolidated debt to capitalization ratio. The filing does not disclose the principal amount of the term loan commitments, so no period-over-period comparisons are available.

• · The credit agreement includes a consolidated debt to capitalization ratio covenant (Section 7.1).
• · Conditions precedent to closing include delivery of a Bond Delivery Agreement and various certificates (Section 5.1).
• · The agreement contains standard representations and warranties, affirmative and negative covenants, and events of default (Sections 4, 6, 7, 8).
• · The agreement is governed by the laws of the State of New York (Section 10.11).
• · The filing does not specify the total commitment amount or the maturity date of the term loan facility.

02-06-2026

Forbright, Inc. filed an amended S-1 registration statement for its initial public offering of 7,900,000 shares of Class A common stock, with an expected price range of $18.00 to $20.00 per share. The company has experienced significant growth, with consolidated assets increasing from $1.9 billion in December 2020 to $8.2 billion as of March 31, 2026, and net income growing from $12.2 million in 2020 to $87.9 million in 2025. However, net income for Q1 2026 was only $11.6 million, suggesting a potential slowdown in earnings momentum compared to the prior year's quarterly run rate.

• · The company has applied to list its Class A common stock on the Nasdaq Global Select Market under the symbol 'FRBT'.
• · Forbright is an 'emerging growth company' and will not be required to have its independent auditor attest to the effectiveness of internal control over financial reporting for as long as it remains an EGC.
• · Digital deposits as of March 31, 2026 were $3.9 billion, gathered since the platform's launch in May 2024, equivalent to the projected deposits of approximately 200 physical bank branches in 24 months.
• · 86.4% of deposits were FDIC-insured as of March 31, 2026.
• · The marginal cost-to-serve for digital deposits was approximately 15 basis points for fiscal year 2025.
• · The middle market represents approximately one-third of private sector GDP and employs approximately 48 million people.
• · No single industry represents more than 20% of the total U.S. middle market.
• · Deposits held by direct banks increased from less than 1% in 2000 to approximately 10% as of December 31, 2025.
• · John Delaney's prior companies made over $50 billion of loans to over 5,000 middle-market companies.

02-06-2026

My Size, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders to be held on July 21, 2026. The meeting will address five proposals: election of two Class II directors (Oron Branitzky and Guy Zimmerman), advisory approval of executive compensation, authorization of a reverse stock split (up to 1-for-30), approval of blank check preferred stock, and ratification of independent auditor Somekh Chaikin. The record date is May 27, 2026, with 4,818,164 shares outstanding. The company incurred a fee of $9,250 plus expenses for proxy solicitation services from Campaign Management.

• · Annual Meeting date: July 21, 2026 at 10:00 a.m. local time at Greenberg Traurig offices in Tel Aviv, Israel.
• · Record date: May 27, 2026.
• · Quorum requirement: one-third of outstanding shares (1,606,055 shares).
• · Proposals include: election of Class II directors, say-on-pay, reverse stock split (ratio range 1-for-2 to 1-for-30, must be completed by July 21, 2027), blank check preferred stock authorization, and auditor ratification.
• · Proxy solicitation by Campaign Management for a fee of $9,250 plus telephone solicitation fees and expenses.
• · Board recommends FOR all proposals.

02-06-2026

Ashok Leyland Limited has informed the stock exchanges of the reaffirmation and assignment of credit ratings by ICRA Limited for various debt instruments totaling ₹7,479.38 Crore. The ratings reaffirmed include [ICRA]AA+ (Stable) for long-term instruments and [ICRA]A1+ for short-term instruments, while a new rating of [ICRA]AA+ (Stable) was assigned for proposed non-convertible debentures of ₹300 Crore. All ratings carry a stable outlook, indicating no immediate negative or positive credit events.

• · The rating action for commercial paper, non-convertible debentures, fund based limits, non-fund based limits, term loan, and unallocated limits is 'Reaffirmed'.
• · A new rating of [ICRA]AA+ (Stable) was assigned to the proposed non-convertible debentures of ₹300 Crore.
• · All long-term ratings carry a 'Stable' outlook, indicating no expected change in credit quality in the near term.
• · The event occurred on June 2, 2026 at 12:51 hours.